Drug
Talazoparib With Enzalutamide
Talazoparib With Enzalutamide: highest development phase Phase 3, developed by Pfizer. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Pfizer
Trials
| Drug | Phase | Indication |
|---|---|---|
| Talazoparib with enzalutamide NCT03395197 | Phase 3 | mCRPC |
Latest
No recent events.
Follow Talazoparib With Enzalutamide on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.